﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Cardiovascular and Thoracic Research</JournalTitle>
      <Issn>2008-5117</Issn>
      <Volume>7</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2015</Year>
        <Month>09</Month>
        <DAY>02</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Correlation of Serum Levels of Vitronectin, Malondialdehyde and Hs-CRP With Disease Severity in Coronary Artery Disease</ArticleTitle>
    <FirstPage>113</FirstPage>
    <LastPage>117</LastPage>
    <ELocationID EIdType="doi">10.15171/jcvtr.2015.24</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Alireza</FirstName>
        <LastName>Yaghoubi</LastName>
      </Author>
      <Author>
        <FirstName>Morteza</FirstName>
        <LastName>Ghojazadeh</LastName>
      </Author>
      <Author>
        <FirstName>Sakhavat</FirstName>
        <LastName>Abolhasani</LastName>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Alikhah</LastName>
      </Author>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Khaki-Khatibi</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/jcvtr.2015.24</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>08</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Vitronectin (VN), malondialdehyde (MDA) and high-sensitivity C-reactive rotein (hs-CRP) are cooperative agents involved in the atherosclerosis process. The study was conducted to assess the correlation of VN, MDA and hs-CRP with the severity of coronary artery disease (CAD). Methods: Parameters such as serum VN, MDA and hs-CRP were measured in 250 subjects including 200 patients with angiographically diagnosed CAD (50 subjects with non-significant CAD, 50 with single vessel disease, 50 with double vessel disease, and 50 with triple vessel disease) and 50 CAD-free subjects as a control group. Serum VN was measured with ELISA; MDA was measured based on reaction with thiobarbituric acid (TBA); and hs-CRP level was measured by a Commercial Kit by Immunoturbidimetry. Results: Serum VN, MDA and hs-CRP were significantly higher in patient groups compared to control group (P &lt; .05). The mean value of MDA between 1 vessel and 3 vessel groups had significant difference (P = .01), also mean value of MDA between 2 vessel and control group and normal group showed significant difference (P &lt; .001). The difference of MDA between 3 vessel and normal and 1 vessel and control group was significant (P &lt; .001). Conclusion: The association and correlation between VN, MDA and hs-CRP indicate their involvement in the atherosclerosis process that may lead to progression of CAD. Also, these findings suggested that serum levels of VN, MDA and hs-CRP can help as diagnostic and monitoring markers in CAD patients and as markers of disease severity.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Vitronectin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">MDA</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Hs-CRP</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Correlation</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">CAD</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Severity</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>